Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer.


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 02 2020
accepted: 16 04 2020
pubmed: 18 5 2020
medline: 6 3 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

Overexpression of tight-junction protein claudin-4 has been detected in primary and metastatic pancreatic cancer tissue and is associated with better prognosis in patients. Noninvasive measurement of claudin-4 expression by imaging methods could provide a means for accelerating detection and stratifying patients into risk groups.

Identifiants

pubmed: 32414951
pii: jnumed.120.243113
doi: 10.2967/jnumed.120.243113
pmc: PMC8679629
doi:

Substances chimiques

Claudin-4 0
Enterotoxins 0
enterotoxin, Clostridium 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1756-1763

Subventions

Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Gastroenterology. 2001 Sep;121(3):678-84
pubmed: 11522752
J Nucl Med. 2015 May;56(5):745-51
pubmed: 25840973
BMC Cancer. 2010 Jul 02;10:349
pubmed: 20598131
Neoplasia. 2012 Oct;14(10):974-85
pubmed: 23097631
J Biol Chem. 2012 Jan 13;287(3):1698-708
pubmed: 22128179
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S491-9
pubmed: 21837532
Prostate. 2012 Mar;72(4):351-60
pubmed: 21656836
J Biol Chem. 1997 Oct 17;272(42):26652-8
pubmed: 9334247
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Semin Cell Dev Biol. 2014 Dec;36:224-31
pubmed: 25239399
Pharmacol Res Perspect. 2016 Sep 27;4(5):e00266
pubmed: 27713828
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947
pubmed: 31648972
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2442-2455
pubmed: 30225616
Gut. 2013 Jul;62(7):1034-43
pubmed: 22677720
J Nucl Med. 2019 Apr;60(4):504-510
pubmed: 30389822
Cancer Res. 2003 Oct 1;63(19):6265-71
pubmed: 14559813
Arch Biochem Biophys. 2012 Aug 1;524(1):64-70
pubmed: 22286027
J Med Chem. 2013 Jun 27;56(12):4966-74
pubmed: 23692562
J Biol Chem. 2008 Jan 4;283(1):268-274
pubmed: 17977833
Biochim Biophys Acta. 2011 Aug;1816(1):73-9
pubmed: 21515339
Biochem Pharmacol. 2008 Apr 15;75(8):1639-48
pubmed: 18342294
J Pharmacol Exp Ther. 2014 Oct;351(1):206-13
pubmed: 25118216
Clin Cancer Res. 2017 Nov 1;23(21):6498-6504
pubmed: 28774899
Clin Nucl Med. 2013 Jan;38(1):1-6
pubmed: 23242037
Ann Nucl Med. 2003 Jun;17(4):261-79
pubmed: 12932109
Mol Imaging Biol. 2018 Apr;20(2):292-299
pubmed: 28842811
Clin Oncol (R Coll Radiol). 2017 Jun;29(6):370-377
pubmed: 28190636
Crit Rev Oncol Hematol. 2016 Mar;99:158-69
pubmed: 26778585
Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1093-102
pubmed: 24522797
Cell. 2010 Dec 23;143(7):1174-89
pubmed: 21183079
PLoS One. 2013 Jun 21;8(6):e67496
pubmed: 23805314
J Biol Chem. 1991 Jun 15;266(17):11037-43
pubmed: 1645721
Am J Clin Pathol. 2004 Feb;121(2):226-30
pubmed: 14983936
Health Technol Assess. 2018 Feb;22(7):1-114
pubmed: 29402376
Int J Oncol. 2016 May;48(5):2124-34
pubmed: 26983776
Int J Mol Sci. 2013 Sep 04;14(9):18148-80
pubmed: 24009024
Sci Rep. 2019 Jun 28;9(1):9405
pubmed: 31253840

Auteurs

Julia Baguña Torres (JB)

Cancer Research United Kingdom and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Michael Mosley (M)

Cancer Research United Kingdom and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Sofia Koustoulidou (S)

Cancer Research United Kingdom and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Samantha Hopkins (S)

Cancer Research United Kingdom and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Stefan Knapp (S)

Institute of Pharmaceutical Chemistry and Structure Genomics Consortium, Goethe-University Frankfurt, Frankfurt am Main, Germany.
German Cancer Network, Mainz-Frankfurt, Germany; and.

Apirat Chaikuad (A)

Institute of Pharmaceutical Chemistry and Structure Genomics Consortium, Goethe-University Frankfurt, Frankfurt am Main, Germany.

Masuo Kondoh (M)

Graduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka, Suita, Osaka, Japan.

Keisuke Tachibana (K)

Graduate School of Pharmaceutical Sciences, Osaka University, Yamadaoka, Suita, Osaka, Japan.

Veerle Kersemans (V)

Cancer Research United Kingdom and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Bart Cornelissen (B)

Cancer Research United Kingdom and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom bart.cornelissen@oncology.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH